| A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness S Yasunaga, M Cohen-Salmon, A El-Amraoui, M Mustapha, N Salem, ... Nature genetics 21 (4), 363-369, 1999 | 680 | 1999 |
| OTOF encodes multiple long and short isoforms: genetic evidence that the long ones underlie recessive deafness DFNB9 S Yasunaga, M Grati, S Chardenoux, TN Smith, TB Friedman, AK Lalwani, ... The American Journal of Human Genetics 67 (3), 591-600, 2000 | 231 | 2000 |
| Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis K Mihara, M Chowdhury, N Nakaju, S Hidani, A Ihara, H Hyodo, ... Blood 107 (1), 305-308, 2006 | 187 | 2006 |
| Extensive HLA class II studies in 58 non‐DRB1* 15 (DR2) narcoleptic patients with cataplexy E Mignot, A Kimura, A Lattermann, X Lin, S Yasunaga, ... Tissue Antigens 49 (4), 329-341, 1997 | 133 | 1997 |
| Different contribution of HLA‐DR and‐DQ genes in susceptibility and resistance to insulin‐dependent diabetes mellitus (IDDM) S Yasunaga, A Kimura, K Hamaguchi, KS Rønningen, T Sasazuki Tissue antigens 47 (1), 37-48, 1996 | 133 | 1996 |
| Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia M Chowdhury, K Mihara, S Yasunaga, M Ohtaki, Y Takihara, A Kimura Leukemia 21 (5), 1116-1122, 2007 | 132 | 2007 |
| DNA typing of HLA class II genes (HLA‐DR,‐DQ and‐DP) in Japanese patients with histiocytic necrotizing lymphadenitis (Kikuchi’s disease) T Tanaka, M Ohmori, S Yasunaga, K Ohshima, M Kikuchi, T Sasazuki Tissue Antigens 54 (3), 246-253, 1999 | 121 | 1999 |
| IL-4 and IL-13: their pathological roles in allergic diseases and their potential in developing new therapies K Izuhara, K Arima, S Yasunaga Current Drug Targets-Inflammation & Allergy 1 (3), 263-269, 2002 | 110 | 2002 |
| Microbiome profile of the amniotic fluid as a predictive biomarker of perinatal outcome D Urushiyama, W Suda, E Ohnishi, R Araki, C Kiyoshima, M Kurakazu, ... Scientific reports 7 (1), 12171, 2017 | 107 | 2017 |
| Dominant‐negative STAT1 SH2 domain mutations in unrelated patients with Mendelian susceptibility to mycobacterial disease M Tsumura, S Okada, H Sakai, S Yasunaga, M Ohtsubo, T Murata, ... Human mutation 33 (9), 1377-1387, 2012 | 84 | 2012 |
| Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasis Y Mizoguchi, M Tsumura, S Okada, O Hirata, S Minegishi, K Imai, ... Journal of leukocyte biology 95 (4), 667-676, 2014 | 82 | 2014 |
| Poly-ADP ribosylation of Miki by tankyrase-1 promotes centrosome maturation Y Ozaki, H Matsui, H Asou, A Nagamachi, D Aki, H Honda, S Yasunaga, ... Molecular cell 47 (5), 694-706, 2012 | 80 | 2012 |
| Synergistic and persistent effect of T‐cell immunotherapy with anti‐CD19 or anti‐CD38 chimeric receptor in conjunction with rituximab on B‐cell non‐Hodgkin lymphoma K Mihara, K Yanagihara, M Takigahira, A Kitanaka, C Imai, ... British journal of haematology 151 (1), 37-46, 2010 | 76 | 2010 |
| Polycomb-group complex 1 acts as an E3 ubiquitin ligase for Geminin to sustain hematopoietic stem cell activity M Ohtsubo, S Yasunaga, Y Ohno, M Tsumura, S Okada, N Ishikawa, ... Proceedings of the National Academy of Sciences 105 (30), 10396-10401, 2008 | 70 | 2008 |
| Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene N Ishikawa, S Okada, M Miki, K Shirao, H Kihara, M Tsumura, ... Journal of medical genetics 45 (12), 802-807, 2008 | 69 | 2008 |
| BMI-1 expression is enhanced through transcriptional and posttranscriptional regulation during the progression of chronic myeloid leukemia J Bhattacharyya, K Mihara, S Yasunaga, H Tanaka, M Hoshi, Y Takihara, ... Annals of hematology 88, 333-340, 2009 | 68 | 2009 |
| Induction and activation of the aryl hydrocarbon receptor by IL-4 in B cells G Tanaka, S Kanaji, A Hirano, K Arima, A Shinagawa, C Goda, ... International immunology 17 (6), 797-805, 2005 | 65 | 2005 |
| Pulmonary involvements of anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis in Japan K Hirayama, M Kobayashi, J Usui, Y Arimura, H Sugiyama, K Nitta, ... Nephrology Dialysis Transplantation 30 (suppl_1), i83-i93, 2015 | 59 | 2015 |
| Analysis of tumor necrosis factor‐α promoter polymorphism in type 1 diabetes: HLA‐B and‐DRB1 alleles are primarily associated with the disease in Japanese K Hamaguchi, A Kimura, N Seki, T Higuchi, S Yasunaga, M Takahashi, ... Tissue Antigens 55 (1), 10-16, 2000 | 52 | 2000 |
| Overexpression of BMI‐1 correlates with drug resistance in B‐cell lymphoma cells through the stabilization of survivin expression J Bhattacharyya, K Mihara, M Ohtsubo, S Yasunaga, Y Takei, ... Cancer science 103 (1), 34-41, 2012 | 44 | 2012 |
